Case series: CYP Inhibition and low dose ibrutinib for steroid-refractory chronic graft-versus-host disease

被引：1
|
作者：
De la Garza-Salazar, Fernando
Colunga-Pedraza, Perla Rocio
Coronado-Alejandro, Edgar Ulises
Gutierrez-Aguirre, Cesar Homero
Cantu-Rodriguez, Olga Graciela
Gomez-Almaguer, David [1 ,2 ]
机构：
[1] Univ Autonoma Nuevo Leon, Fac Med, Monterrey, Mexico
[2] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Hematol Serv, Internal Med Dept, Monterrey, Mexico
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷 / 03期
关键词：
chronic graft versus host disease; CYP; ibrutinib; itraconazole; low dose;
D O I：
10.1111/bjh.18712
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：573 / 576
页数：4
相关论文
共 50 条
  • [11] Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study
    Shiratori, Souichi
    Fukushima, Kentaro
    Onishi, Yasushi
    Doki, Noriko
    Goto, Tatsunori
    Okada, Masaya
    Nakamae, Hirohisa
    Maeda, Yoshinobu
    Kato, Koji
    Ishikawa, Takayuki
    Kondo, Tadakazu
    Toyosaki, Masako
    Ikeda, Takashi
    Uchida, Naoyuki
    Maki, Akio
    Shimada, Fumika
    Tajima, Takeshi
    Stefanelli, Tommaso
    Teshima, Takanori
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (06) : 705 - 716
  • [12] Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis
    Fan, Shuang
    Huo, Wen-Xuan
    Yang, Yang
    Shen, Meng-Zhu
    Mo, Xiao-Dong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [13] Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis
    Kharfan-Dabaja, Mohamed A.
    Mhaskar, Asmita R.
    Djulbegovic, Benjamin
    Cutler, Corey
    Mohty, Mohamad
    Kumar, Ambuj
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) : 1005 - 1013
  • [14] Systematic Review and Meta-Analysis of Extracorporeal Photopheresis for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease
    Defilipp, Zachariah
    Fox, Laura
    Holderried, Tobias A. W.
    Mehra, Varun
    Michonneau, David
    Pashley, Alex
    Karlsson, Andrei
    Kim, Dennis Dong Hwan
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (02): : 76e1 - 76e13
  • [15] Phase I Trial of Brentuximab Vedotin for Steroid-Refractory Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
    DeFilipp, Zachariah
    Li, Shuli
    Kempner, Maria E.
    Brown, Jami
    Del Rio, Candice
    Valles, Betsy
    Hunnewell, Chrisa
    Saylor, Meredith
    Vanderklish, Julie
    Dey, Bimalangshu R.
    El-Jawahri, Areej
    McAfee, Steven L.
    Spitzer, Thomas R.
    Chen, Yi-Bin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (09) : 1836 - 1840
  • [16] An Open-Label, Single-Arm, Multicenter Study of Ibrutinib in Japanese Patients With Steroid-dependent/Refractory Chronic Graft-Versus-Host Disease
    Doki, Noriko
    Toyosaki, Masako
    Shiratori, Souichi
    Osumi, Tomoo
    Okada, Masaya
    Kawakita, Toshiro
    Sawa, Masashi
    Ishikawa, Takayuki
    Ueda, Yasunori
    Yoshinari, Nozomi
    Nakahara, Susumu
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 867.e1 - 867.e9
  • [17] Chronic graft-versus-host disease
    Cutler, C
    Antin, JH
    CURRENT OPINION IN ONCOLOGY, 2006, 18 (02) : 126 - 131
  • [18] Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy
    E Bisaccia
    M Palangio
    J Gonzalez
    K R Adler
    S D Rowley
    S L Goldberg
    Bone Marrow Transplantation, 2003, 31 : 291 - 294
  • [19] Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy
    Bisaccia, E
    Palangio, M
    Gonzalez, J
    Adler, KR
    Rowley, SD
    Goldberg, SL
    BONE MARROW TRANSPLANTATION, 2003, 31 (04) : 291 - 294
  • [20] Chronic graft-versus-host disease
    Horwitz, ME
    Sullivan, KM
    BLOOD REVIEWS, 2006, 20 (01) : 15 - 27
12345